Table 2.
Items |
miR‐125a relative expression |
P value |
miR‐125b relative expression |
P value |
---|---|---|---|---|
Gender | ||||
Male | 1.2 (0.8‐1.4) | .968 | 1.5 (1.0‐2.2) | .731 |
Female | 1.0 (0.8‐1.6) | 1.6 (1.0‐2.6) | ||
Smoke | ||||
Yes | 1.2 (0.7‐1.7) | .360 | 1.9 (1.0‐3.2) | .097 |
No | 1.1 (0.8‐1.4) | 1.5 (0.9‐2.3) | ||
COPD | ||||
Yes | 1.2 (0.9‐1.6) | .733 | 1.8 (1.0‐2.6) | .727 |
No | 1.2 (0.8‐1.4) | 1.6 (1.0‐2.4) | ||
Cardiomyopathy | ||||
Yes | 1.2 (1.0‐1.6) | .015 | 2.1 (1.0‐3.0) | .094 |
No | 1.0 (0.6‐1.4) | 1.5 (0.9‐2.1) | ||
Chronic kidney failure | ||||
Yes | 0.9 (0.7‐1.6) | .366 | 0.8 (0.2‐3.4) | .395 |
No | 1.2 (0.8‐1.5) | 1.6 (2.0‐2.4) | ||
Cirrhosis | ||||
Yes | 1.2 (0.8‐1.6) | .785 | 1.2 (1.0‐1.8) | .195 |
No | 1.1 (0.8‐1.5) | 1.8 (0.9‐2.6) |
Data were presented as median (25th‐75th quantiles). Comparison was determined by Wilcoxon rank sum test. P value <.05 was considered significant.
Abbreviation: COPD, chronic obstructive pulmonary disease.